SomaLogic proteomics reveals new biomarkers and provides mechanistic, clinical insights into Acetyl coA Carboxylase (ACC) inhibition in Non-alcoholic Steatohepatitis (NASH).
第一作者:
Pitchumani,Sivakumar
第一单位:
Translational Clinical Sciences, Pfizer Research and Development, 500 Arcola Road, Collegeville, PA, 19426, USA. pitchumani.sivakumar@pfizer.com.
作者:
医学主题词
人类(Humans);乙酰CoA羧化酶(Acetyl-CoA Carboxylase);蛋白质组学(Proteomics);女(雌)性(Female);男(雄)性(Male);成年人(Adult);中年人(Middle Aged);肝(Liver);酶抑制剂(Enzyme Inhibitors)
DOI
10.1038/s41598-024-67843-8
PMID
39048608
发布时间
2024-12-10
- 浏览0
Scientific reports
17072页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



